Quantity and quality of skeletal muscle is a more accurate measure for determining dose and of potential treatment-related toxicity in patients receiving chemotherapy for early-stage breast cancer.
Researchers report that clinicians may want to start collecting toxicity data routinely and offering early interventions to patients with breast cancer.
Patients with chronic lymphocytic leukemia (CLL) who discontinue TKI therapy due to toxicity can successfully be treated with an alternate TKI.
Treatment with epidermal growth factor receptor tyrosine kinase inhibitors has been linked to earlier paronychia onset and more dermatological visits for skin toxic effects.
This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation.
Two studies show benefits for hypofractionated versus conventionally fractionated whole-breast irradiation.
Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.
Managing toxicity costs are higher for treatment with less-specific targeted agents and chemotherapies.
Standard and reduced high-dose volume RT for muscle-invasive bladder cancer provides comparable tumor control and decreased late toxicity compared with surgery, according to a new study.
A whole new class of drugs has been developed that targets the structure of the cancer cell for the first time.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations
- Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Shared Decision-making Visits Improved Comfort With Lung Cancer Screening Decisions
- Temozolomide With Radiotherapy for Glioblastoma Provides Some Survival Benefit in Elderly
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|